{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:54:59Z","timestamp":1787698499454,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021069","name":"Indivior Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.drugalcdep.2025.112798","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T06:31:29Z","timestamp":1752906689000},"page":"112798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: The FASTER-BUP udy"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2556-7049","authenticated-orcid":false,"given":"M. Eugenia","family":"Socias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piper","family":"Dickhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0028-9209","authenticated-orcid":false,"given":"Jenna","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonaid","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2025.112798_bib1","unstructured":"Ahmad, F.B., Cisewski, J.A., Rossen, L.M., 2025. Provisional Drug Overdose Data [WWW Document]. URL \u3008https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm\u3009 (accessed 1.16.25)."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib2","unstructured":"BC Coroners Service, 2024. Unregulated Drug Deaths - Summary [WWW Document]. URL \u3008https:\/\/app.powerbi.com\/view?r=eyJrIjoiZThmOTkxMzgtZWUzNS00ODk1LWJiZjItYzMyMTFjNmY0MzJiIiwidCI6IjZmZGI1MjAwLTNkMGQtNGE4YS1iMDM2LWQzNjg1ZTM1OWFkYyJ9\u3009 (accessed 1.16.25)."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/SAR.S108302","article-title":"Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system","volume":"7","author":"Boscarino","year":"2016","journal-title":"Subst. Abus. Rehabil."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34540","article-title":"Buprenorphine dose and time to discontinuation among patients with opioid use disorder in the era of fentanyl","volume":"6","author":"Chambers","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1037\/0022-006X.68.1.134","article-title":"The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties","volume":"68","author":"Fals-Stewart","year":"2000","journal-title":"J. Consult Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib6","unstructured":"Federal, provincial, and territorial Special Advisory Committee on Toxic Drug Poisonings, n.d. Opioid- and Stimulant-related Harms in Canada [WWW Document]. URL \u3008https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/graphs.html?ind=10&unit=0\u3009 (accessed 1.16.25)."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2017.7818","article-title":"Medication-assisted treatment and opioid use before and after overdose in pennsylvania medicaid","volume":"318","author":"Frazier","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","article-title":"Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"393","author":"Haight","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201093","article-title":"Cross-sectional validation of the PROMIS-preference scoring system","volume":"13","author":"Hanmer","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib10","article-title":"Evaluation of an injectable monthly extended-release buprenorphine program in a low-barrier specialty addiction medicine clinic","volume":"156","author":"Heil","year":"2024","journal-title":"J. Subst. Use Addict. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111032","article-title":"Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: a population-based cohort study in Ontario, Canada","volume":"254","author":"Iacono","year":"2024","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/29767342231222103","article-title":"The FASTER-BUP study, extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: protocol for an observational prospective study","volume":"45","author":"Langlois","year":"2024","journal-title":"Subst. Use Addict. J."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.11.004","article-title":"Effects of monthly buprenorphine extended-release injections on patient-centered outcomes: a long-term study","volume":"110","author":"Ling","year":"2020","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib16","article-title":"Cost-effectiveness of buprenorphine-naloxone versus extended-release naltrexone to prevent opioid relapse","author":"Murphy","year":"2018","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109375","article-title":"Development and validation of health system performance measures for opioid use disorder in British Columbia, Canada","volume":"233","author":"Nosyk","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.24095\/hpcdp.38.9.04","article-title":"Patterns of health care utilization among people who overdosed from illegal drugs: a descriptive analysis using the BC Provincial Overdose Cohort","volume":"38","author":"Otterstatter","year":"2018","journal-title":"Health Promot Chronic Dis. Prev. Can."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib19","doi-asserted-by":"crossref","first-page":"m772","DOI":"10.1136\/bmj.m772","article-title":"Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study","volume":"368","author":"Pearce","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108316","article-title":"Real-world outcomes with extended-release buprenorphine (XR-BUP) in a low threshold bridge clinic: a retrospective case series","volume":"126","author":"Peckham","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib21","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2025.112798_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108661","article-title":"Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine","volume":"136","author":"Stein","year":"2022","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib23","unstructured":"Sublocade Product Monograph [WWW Document], n.d. Drug and Health Product Portal Canada. URL \u3008https:\/\/dhpp.hpfb-dgpsa.ca\/dhpp\/resource\/97349\u3009 (accessed 5.1.25)."},{"key":"10.1016\/j.drugalcdep.2025.112798_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.schres.2010.01.021","article-title":"Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients","volume":"118","author":"Vernon","year":"2010","journal-title":"Schizophr. Res."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:50:03Z","timestamp":1772772603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625002510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":24,"alternative-id":["S0376871625002510"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112798","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: The FASTER-BUP udy","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112798"}}